NFKB1 and cancer: Early evidence of māmaki’s potential anti-inflammatory and chemopreventive capabilities has been demonstrated by Sun et al.’s (2022) report, where inhibition of the proinflammatory NF-κB signaling and cancer macrophage NO production was shown [9].